Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Home
Profiles
Research units
Research output
Prizes
Search by expertise, name or affiliation
Major bleeding caused by warfarin in a genetically susceptible patient
Aharon Bloch
, Eldad Ben-Chetrit
,
Mordechai Muszkat
, Yoseph Caraco
*
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
peer-review
16
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Major bleeding caused by warfarin in a genetically susceptible patient'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
CYP2C9
100%
Allele
50%
Genetics
50%
Anticoagulation
50%
Isoenzyme
50%
Genetic Carrier
50%
Heterozygote
50%
Fresh Frozen Plasma
50%
CYP2C9*3
50%
Gene Mutation
50%
Blood Plasma
50%
Cytochrome P450
50%
Keyphrases
Warfarin
100%
Major Bleeding
100%
CYP2C9
37%
International Normalized Ratio
25%
Genetic Modification
12%
Genetic Analysis
12%
Compound Heterozygous mutation
12%
Cytochrome P450 Enzymes
12%
Enhanced Sensitivity
12%
Life-threatening Complications
12%
Older Women
12%
Fresh Frozen Plasma
12%
Patient Plasma
12%
Variant Allele
12%
Transfusion
12%
90 Years Old
12%
Gastrointestinal Bleeding
12%
Anticoagulation Effect
12%
Pharmacology, Toxicology and Pharmaceutical Science
Warfarin
100%
Bleeding
100%
CYP2C9
25%
Cytochrome P450 Isoenzyme
12%
CYP2C9*3
12%
Gastrointestinal Hemorrhage
12%
Fresh Frozen Plasma
12%